Nature Communications (Apr 2021)

Exploiting pyocyanin to treat mitochondrial disease due to respiratory complex III dysfunction

  • Roberta Peruzzo,
  • Samantha Corrà,
  • Roberto Costa,
  • Michele Brischigliaro,
  • Tatiana Varanita,
  • Lucia Biasutto,
  • Chiara Rampazzo,
  • Daniele Ghezzi,
  • Luigi Leanza,
  • Mario Zoratti,
  • Massimo Zeviani,
  • Cristiano De Pittà,
  • Carlo Viscomi,
  • Rodolfo Costa,
  • Ildikò Szabò

DOI
https://doi.org/10.1038/s41467-021-22062-x
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 19

Abstract

Read online

Mitochondrial diseases, including those caused by defects in complex III of the respiratory chain, lack curative treatments. Here the authors report that the small molecule pyocyanin has beneficial effects in cells derived from patients with complex III-deficiency as well as in fly and zebrafish genetic models with reduced complex III activity.